| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |